Publication |
Data |
|
Phenotype
|
Chaturantabut et al., 2019
|
Fig. 4
|
|
|
Shen et al., 2016
|
Fig. 6
|
|
|
Kearns et al., 2015
|
Fig. 2
|
|
- spinal cord central nervous system myelination decreased occurrence, abnormal
- spinal cord has fewer parts of type oligodendrocyte, abnormal
- spinal cord myelin sheath decreased thickness, abnormal
- spinal cord oligodendrocyte cldnk expression decreased amount, abnormal
- spinal cord oligodendrocyte mbpa expression decreased amount, abnormal
- spinal cord oligodendrocyte plp1a expression decreased amount, abnormal
- spinal cord oligodendrocyte ab1-mbp labeling decreased amount, abnormal
- whole organism dhrs12 expression decreased amount, abnormal
- whole organism fdps expression decreased amount, abnormal
- whole organism hmgcra expression decreased amount, abnormal
- whole organism hmgcs1 expression decreased amount, abnormal
- whole organism mbpa expression decreased amount, abnormal
- whole organism mpz expression decreased amount, abnormal
- whole organism cholesterol biosynthetic process decreased occurrence, abnormal
|
|
Fig. 3
|
|
|
|
Fig. 4
|
|
|
Ding et al., 2011
|
Fig. 3
|
|
|
|
text only
|
|
|